Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Jane L. Liesveld, M.D.
Jane L. Liesveld, M.D.

Jane L. Liesveld, M.D.

Medicine — Hematology/Oncology — Internal Medicine

Accepting New Patients

Jane L. Liesveld, M.D.

Medicine — Hematology/Oncology — Internal Medicine

Accepting New Patients


Locations

James P. Wilmot Cancer Center
601 Elmwood Ave.
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-5823

print

Fax

(585) 273-1051

About Me

While the doctor-patient relationship is one of potential intensity and privacy, the best patient care comes from teamwork, which values all who contribute to achieving high-quality care with compassion. Providing patients and their families with the knowledge and means to be partners in care is one of my key roles as a physician.

When a patient is diagnosed with a blood cancer or chronic blood condition, it is often the start of a new journey that will be the beginning of great change. Walking with patients through this journey from start to finish, and offering therapy and guidance along the way, is a source of professional and personal satisfaction for me. Hematology/oncology is a field where clinical and basic research can be rapidly applied to improve outcomes and quality of life.

I grew up in the Midwest, but have lived in Rochester since I began my post-doctoral medical training. My association with Strong, the University of Rochester and the people in our community and surrounding areas has enriched my life. I feel privileged to work in such a wonderful environment. I have expertise in novel therapies for acute myeloid leukemia, stem cell mobilization and homing, as well as stem cell transplantation.

Conditions I Treat

- Leukemia, all types
- Myeloproliferative disorders
- Myelodysplastic syndromes
- Multiple myeloma
- Stem cell transplantation

Dr. Liesveld admits to:

Strong Memorial Hospital

Credentials

Education:

MD | University of Iowa College of Medicine — 1980

Post-doctoral Training & Residency:

Internship in Medicine at University of Rochester Medical Center — 1980 - 1981
Residency in Medicine at University of Rochester Medical Center — 1981 - 1984
Fellowship in Oncology at University of Rochester Medical Center — 1987 - 1988
Fellowship in Hematology at University of Rochester Medical Center — 1984 - 1987
Research in Hematology Research Fellowship at University of Rochester Medical Center — 1988 - 1989

Research

Effects of oxygen metabolites/chemokines on hematopoietic stem cell expansion and preservation.

Effects of hematopoietic growth factors and inhibitors on AML blast proliferation (correlative clinical studies)

Effects of hematopoietic stem cell adhesion on marrow stromal cell cytokine production.

Role of signal transduction inhibition in treatment of acute myelogenous leukemia/myelodysplasia.

Characterization of mobilized peripheral blood stem cells

Publications:

Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, Defilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA. "Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields are Less." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2017 Sep 25; Epub 2017 Sep 25.

Hunter BD, Herr M, Meacham PJ, Barlaskar F, Evans AG, Burack WR, Liesveld JL, Becker MW, Milner LA, Constine LS, Dhakal S, Barr PM, Friedberg JW, Casulo C. "Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era." Clinical lymphoma, myeloma & leukemia.. 2017 Mar 0; 17(3):145-151. Epub 2016 Nov 23.

Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee JW, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. "Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study." Bone marrow transplantation.. 2017 Feb 0; 52(2):270-278. Epub 2016 Dec 19.

View All Publications